Notice of Participation of NIBIB in "RFA-NS-22-022 HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)"
Notice Number:
NOT-EB-23-015

Key Dates

Release Date:

July 24, 2023

Related Announcements

  • December 15, 2022 - Career Transition Award/Research Transition Award - HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed). See NOFO RFA-NS-22-022.

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this notice is to inform potential applicants that the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is participating in RFA-NS-22-022, "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed), effective immediately.

The following sections of RFA-NS-22-022 have been modified to reflect NIBIB's participation in this NOFO.

Part 1. Overview Information

Components of Participating Organizations

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Assistance Listing Number(s)

93.286, 93.865

Section VII. Agency Contacts

Scientific/Research Contact(s)

Tina Gatlin, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 240-731-3794
Email: [email protected]

Financial/Grants Management Contact(s)

Mutema Nyankale
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 240-921-3990
Email: [email protected]

Inquiries

Please direct all inquiries to:

Tina Gatlin, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 240-731-3794
Email: [email protected]